Musical Shares
2 weeks ago
It appears that there is a new docket for a deposition on December 20th. That means the trial will not be till next year with Fluent.
Which means, I believe, nothing with this "company."
On another note, the responses from Fluent on the main arguments have been nothing short of very good.
The main argument posed by Feldenkrais is that there was no contamination on the site when Fluent was there. However, the Plaintiff's (CIGN/MF) own "expert witness" that testified never disputes the fact that heavy metals were present on the site. Talk about a huge laugh.
Even worse, the whole argument for the Plaintiff's "non-contaminated" facility from the "expert witness" is the semantics of the word "contaminated." Which Fluent is trying to throw out. It's absolutely absurd.
He also confirms that the metrics he uses for determining whether the site meets his particular definition of “contaminated” are completely unrelated to the standards for human inhalation or ingestion or any standards specific to medical marijuana cultivation.
In my opinion, Fluent absolutely squashes every argument made by CIGN/MF.
I think Fluent has a stronger position. As I have always said.
Musical Shares
1 month ago
A fourth lawsuit against CIGN/CATV is taking place. 4 lawsuits are now open against him.
$500,000 convertible note to Genetic Networks for their "screening platform." How pathetic. And we have no idea what the terms of the contract nor conversion is.
His new "business idea" now is:
These products will be an add-on to the laboratory compliance testing currently
being done in the industry. Using 8,000 records of genes and compounds we will map a path to medical
indications for cannabis derived products. The cannabis producers will be able to say that their product
has activity against targets that are involved in medical indications, suggesting that there may be efficacy
in these disease spaces (just like a supplement claim, versus a medicinal claim).
Another bogus idea that has already been done or is completely worthless because there is no validation.
This is the wrong path that won't generate any real revenues. I'm sure this will fall apart like everything else. After all, he said he was doing "machine learning" for cannabis analytics in 2020. So, now it's this? Just another ploy.
The worst is yet to come. What a complete joke.
Musical Shares
1 month ago
I can't stop laughing.
Look at the price! No one is being fooled here. Kudos.
Looks like people are starting to buzz about an "update" on the OTC markets website
We will expand our operations to provide services to all Cannabis companies by and through the Cannabis laboratories performing compliance tests on their products and add date to the Compliance Certificates of Analysis that will give predictive medical use to the patients much like a supplement has medical indications,
So now he is going to do compliance tests that give predictive medical use to patients?
First of all, what is "add date?" What does it mean to "add date" to CCA's that will give it predictive medical use?
Second of all, this is not a huge advancement of the medical cannabis industry. This is nothing more than labeling a certain strain of marijuana (or cannabis product) for a certain "possible medical intervention."
This has already been done before and is being advanced by other companies. There are literally databases that have this information on many cannabis related products.
Third of all, there is nothing unique that other entrepreneurs can't do to compete. There are numerous screening platforms out there.
I don't know which is worse, when he said he uses "machine learning" for cannabis analytics 4 years ago or this. Is this just another ploy?
On a side note, Fluent looks good in their responses on the lawsuit.
jedijazz
2 months ago
$CATV July 2nd Press Release - Investor Updates: https://catvbt.com/category-v-biotech-inc-announces-exclusive-licensing-of-genetic-networks-intellectual-property-for-cannabis-applications/
Category V Biotech, Inc. (OTC: CATV), formerly known as 4Cable TV International, Inc., is pleased to announce significant progress in our relationship with Genetic Networks, LLC